|
 |
European Pharmaceutical Contractor
|
It is always a challenge to design a novel programme for a conference which deals with the central laboratory sector. Too often you have heard the presentations before or they contain nothing new. They are attended by the same old people with little new to say, no new views to air. But it isn't as though central laboratories have not evolved over the years - indeed they have developed enormously. The service part of their offering has become key while their analytical skills have almost come to be taken for granted. Thus, the core competencies of a first class central laboratory increasingly have had little to do with analysis, hence the title of this conference, held in the elegant and decadent surroundings of the Royal Park at Evian-les Bains - 'a bloodless coup'.
The analysis of samples taken in the course of a clinical trial may contribute to up to 50 per cent of the data presented to the regulators and around the same percentage of cost. For the time being at least, clinical trials continue to grow in terms of numbers of patients, the number of parameters measured for each patient, and the diversity of countries in which the trials are carried out. This is one of the increasing challenges for the central lab - how to cope with the ever-growing logistic scale of the trial. The way that trials are conducted is also beginning to change, albeit slowly. Electronic data capture (EDC), remote data entry (RDE), interactive voice response systems (IVRS) and so on, are all playing an increasing role in clinical trials. Therefore the labs have to keep abreast of this trend and ideally anticipate it.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
